Archive: 16/11/2015
Adverse trends in mental health linked to disability assessments
A National Institute for Health Research (NIHR) funded study by public health experts from the University of Liverpool has found that the programme of reassessing people on disability benefits may have had an adverse effect ...
Nov 16, 2015
Johnson & Johnson multiple myeloma drug wins accelerated OK
A Johnson & Johnson drug won Food and Drug Administration approval Monday for treating the incurable blood cancer multiple myeloma in patients who've failed prior therapies and have few options left.
Nov 16, 2015
Medicare launches major payment shift for hip, knee surgery
Medicare is launching a major shift in how it pays for hip and knee replacements. The goal: improve quality and control costs.
Nov 16, 2015
FDA approves new therapy option for lung cancer patients who develop resistance to early generation EGFR inhibitors
The International Association for the Study of Lung Cancer (IASLC) commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced ...
Nov 16, 2015
Research points to why some colorectal cancers recur after treatment
Cetuximab, marketed as Erbitux, is one of the key therapies for metastatic colorectal cancer. Yet the cancer still returns in some patients, shortening overall survival.
Nov 16, 2015